HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

• Mykola Pinkevych,

  Affiliation Centre for Vascular Research, University of New South Wales, Sydney, Australia

  ⨯
• Deborah Cromer,

  Affiliation Centre for Vascular Research, University of New South Wales, Sydney, Australia

  ⨯
• Martin Tolstrup,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Andrew J. Grimm,

  Affiliation Centre for Vascular Research, University of New South Wales, Sydney, Australia

  ⨯
• David A. Cooper,

  Affiliation Kirby Institute, University of New South Wales, Sydney, Australia

  ⨯
• Sharon R. Lewin,

  Affiliations Peter Doherty Institute for Infection and Immunity, Melbourne, Australia, Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia

  ⨯
• Ole S. Søgaard,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Thomas A. Rasmussen,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Stephen J. Kent,

  Affiliation Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

  ⨯
• Anthony D. Kelleher,

  Affiliation Kirby Institute, University of New South Wales, Sydney, Australia

  ⨯
• Miles P. Davenport

  * E-mail: m.davenport@unsw.edu.au

  Affiliation Centre for Vascular Research, University of New South Wales, Sydney, Australia

  ⨯